Jeffrey S. Weber

Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.

Jedd D. Wolchok, Antoni Ribas, Richard F. Kefford, 2016 .

Clonal Architectures and Driver Mutations in Metastatic Melanomas

Li Ding, Malachi Griffith, Joshua F. McMichael, 2014, PloS one.

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

Mario Roederer, Mark M. Davis, S. Swetter, 1999, Nature Medicine.

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Axel Hoos, Jedd D. Wolchok, J. Wolchok, 2009, Clinical Cancer Research.

Classification of current anticancer immunotherapies

Axel Hoos, Patrizia Agostinis, Fernando Aranda, 2014, Oncotarget.